Skip to content
Home/Companies/MedTech/Neurobell
Neurobell

Neurobell

MedTech·Ireland·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Neurobell?

Neurobell is an Irish MedTech company, currently owned by Atlantic Bridge Capital since 2024.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Atlantic Bridge Capital
Investor
Atlantic Bridge Capital
University Bridge Fund II · 2021 · VC

Key facts

HQIreland
SectorMedTech
Websiteneurobell.com

More from University Bridge Fund II

Other portfolio companies in the same fund.

LaNua Medica
LaNua Medica
Active
MedTechIreland· 2024
Vertigenius
Vertigenius
Active
TMTIreland· 2024
Micron Agritech
Micron Agritech
Active
IndustrialsIreland· 2023
ProVerum
ProVerum
Active
MedTechIreland· 2022
Trustap
Trustap
Active
SoftwareIreland· 2022
Ubotica
Ubotica
Active
TMTIreland· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Neurobell?

Neurobell is currently owned by Atlantic Bridge Capital, through University Bridge Fund II, since 2024.

When did Atlantic Bridge Capital acquire Neurobell?

Atlantic Bridge Capital acquired Neurobell in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue